标题
Differentiated thyroid carcinomas may elude the immune system by B7H1 upregulation
作者
关键词
-
出版物
ENDOCRINE-RELATED CANCER
Volume 20, Issue 1, Pages 103-110
出版商
Bioscientifica
发表日期
2012-11-30
DOI
10.1530/erc-12-0313
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Common -Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands
- (2014) A. L. Kinter et al. JOURNAL OF IMMUNOLOGY
- Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer
- (2012) Lucas Leite Cunha et al. ENDOCRINE-RELATED CANCER
- Phenotypical Analysis of Lymphocytes with Suppressive and Regulatory Properties (Tregs) and NK Cells in the Papillary Carcinoma of Thyroid
- (2012) Foteini Gogali et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Programmed Death-1+T Cells and Regulatory T Cells Are Enriched in Tumor-Involved Lymph Nodes and Associated with Aggressive Features in Papillary Thyroid Cancer
- (2012) Jena D. French et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- B7-H1 expression is associated with expansion of regulatory T cells in colorectal carcinoma
- (2012) Dong Hua WORLD JOURNAL OF GASTROENTEROLOGY
- Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas
- (2011) Jie Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunoregulatory Molecule B7-H1 (CD274) Contributes to Skin Carcinogenesis
- (2011) Y. Cao et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Use of sodium iodide symporter expression in differentiated thyroid carcinomas
- (2011) Elaine C. Morari et al. CLINICAL ENDOCRINOLOGY
- Concurrent lymphocytic thyroiditis is associated to less aggressive papillary thyroid carcinomas
- (2011) Lucas Leite Cunha et al. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
- Reduced tumor-antigen density leads to PD-1/PD-L1-mediated impairment of partially exhausted CD8+ T cells
- (2011) Andrew D. Kaiser et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- Overall survival and PD-L1 expression in metastasized malignant melanoma
- (2010) Jules Gadiot et al. CANCER
- B7-H1 Overexpression Regulates Epithelial–Mesenchymal Transition and Accelerates Carcinogenesis in Skin
- (2010) Yujia Cao et al. CANCER RESEARCH
- Muc-1 Expression May Help Characterize Thyroid Nodules but Does Not Predict Patients’ Outcome
- (2010) Elaine Cristina Morari et al. ENDOCRINE PATHOLOGY
- PD-L1 expression on tolerogenic APCs is controlled by STAT-3
- (2010) Sabine J. Wölfle et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor-Associated Lymphocytes and Increased FoxP3+Regulatory T Cell Frequency Correlate with More Aggressive Papillary Thyroid Cancer
- (2010) Jena D. French et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Significance of B7-H1 and B7-1 Expressions in Pancreatic Carcinoma
- (2010) Liancai Wang et al. WORLD JOURNAL OF SURGERY
- Automated Cellular Imaging System III for Assessing HER2 Status in Breast Cancer Specimens
- (2009) Douglas M. Minot et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- FOXP3 Expression and Overall Survival in Breast Cancer
- (2009) Andrea Merlo et al. JOURNAL OF CLINICAL ONCOLOGY
- B7-H1 is correlated with malignancy-grade gliomas but is not expressed exclusively on tumor stem-like cells
- (2009) Yu Yao et al. NEURO-ONCOLOGY
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
- (2009) David S. Cooper et al. THYROID
- B7-H1 Expression in Wilms Tumor: Correlation With Tumor Biology and Disease Recurrence
- (2008) Jonathan C. Routh et al. JOURNAL OF UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now